Inspira Technologies Oxy B.H.N. Ltd. Insider Trading

IINN

⊜ Compare

Last 12 months

Insiders bought 181K and sold 399K on the open market.

62% of the selling was scheduled in advance under 10b5-1 plans.

Net open-market

−218K

4 buys · 3 sales

Under a 10b5-1 plan

62%

of the value sold

Insiders who bought / sold

2 / 2

executives and directors

Last open-market buy

Oct 2026

Oct 15, 2026

Get an email when IINN's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 15	Tal Parnes Director	Bought	6,666	$1.50	10K	0.9%	Form 4
Oct 13	Dagi Shahar Ben-Noon Chief Executive Officer	Bought	14,093	$1.49	21K	0.4%	Form 4
Oct 9	Dagi Shahar Ben-Noon Chief Executive Officer	Bought	18,181	$1.67	30K	0.5%	Form 4
Sep 28	Dagi Shahar Ben-Noon Chief Executive Officer	Bought	168,894	$0.71	120K	4.9%	Form 4
May 29 – Jun 1	Yafit Tehila Chief Financial Officer	Sold10b5-1 plan 2 parts	30,000	$3.50 average	105K	3.3%	Form 4
May 29	Hayon Daniella Yechezkely Chief Technology Officer	SoldNo plan	50,000	$3.00	150K	6.0%	Form 4
May 27 – 28	Yafit Tehila Chief Financial Officer	Sold10b5-1 plan 4 parts	60,000	$2.40 average	144K	6.3%	Form 4

Oct 15
Tal Parnes
Director · bought 6,666 at $1.50
10K
0.9% of stake
Oct 13
Dagi Shahar Ben-Noon
Chief Executive Officer · bought 14,093 at $1.49
21K
0.4% of stake
Oct 9
Dagi Shahar Ben-Noon
Chief Executive Officer · bought 18,181 at $1.67
30K
0.5% of stake
Sep 28
Dagi Shahar Ben-Noon
Chief Executive Officer · bought 168,894 at $0.71
120K
4.9% of stake
May 29 – Jun 110b5-1 plan
Yafit Tehila
Chief Financial Officer · sold 30,000 at avg $3.50
105K
3.3% of stake
May 29No plan
Hayon Daniella Yechezkely
Chief Technology Officer · sold 50,000 at $3.00
150K
6.0% of stake
May 27 – 2810b5-1 plan
Yafit Tehila
Chief Financial Officer · sold 60,000 at avg $2.40
144K
6.3% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch IINN, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Medical Devices · Pick stocks to compare with IINN

CompareIntrinsic value

RDHLRedHill Biopharma Ltd. American

$0.42+1.44%10

XLS.XSWXXlife Sciences AG

CHF 9.44+8.51%0

ALOPM.XPAROncodesign Precision Medicine

€0.26-0.38%41

GDTCCytoMed Therapeutics Ltd.

$0.89-2.31%20

QLIFE.XSTOQlife Holding AB

€0.07-4.81%0

ALNEV.XPARNeovacs S.A.

€0.09-4.78%40

ALHYG.XPARHybrigenics SA

€0.01+3.03%15

EVG.XLONEvgen Pharma PLC

£0.00+1.18%40

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing IINN

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.